FdaApplication
ANDA 211325
Identifiers
- fda_app_no: ANDA211325
Properties
| Property | Value |
|---|---|
| applicant_name | CADILA PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2019-05-13 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 200MG | TABLET;ORAL |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 300MG | TABLET;ORAL |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 100MG | TABLET;ORAL |
3 products